-
Breaking Down Gilead Sciences: 22 Analysts Share Their Views
29 Jan 2025 15:24 GMT
… date on Gilead Sciences analyst ratings.
Unveiling the Story Behind Gilead Sciences
Gilead Sciences develops and … company's top-line earnings. As compared to competitors, the … for metrics like growth estimates, earnings, and revenue, offering investors a …
-
Trading Q4 Earnings: Will Bulls Fly or Just Get Gored?
30 Jan 2025 14:34 GMT
… Cautious, Markets Wobble
Despite strong earnings growth projections, investor sentiment isn … -week for 2024’s Q4 earnings season.
Earnings dates are subject to … ;21/2025
GILD UW
Gilead Sciences Inc
2.29%
2…
-
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
29 Dec 2024 15:02 GMT
… .
The company's Q3 earnings show strong performance in HIV … The last time I covered Gilead Sciences (NASDAQ:GILD) for Seeking Alpha … the company's Q2 earnings, and assigned a "Hold …
-
Gilead Sciences's Earnings: A Preview
05 Nov 2024 15:24 GMT
… Gilead Sciences to report an earnings per share (EPS) of $1.55.
Gilead Sciences … going into this earnings release.
Analyst Views on Gilead Sciences
Understanding market …
To track all earnings releases for Gilead Sciences visit their earnings calendar on our …
-
Looking At Gilead Sciences's Recent Unusual Options Activity
03 Dec 2024 21:14 GMT
… 5K
3.2K
20
About Gilead Sciences
Gilead Sciences develops and markets therapies to … Trodelvy (from Immunomedics).
Where Is Gilead Sciences Standing Right Now?
Currently trading … .
Anticipated earnings release is in 63 days.
Expert Opinions on Gilead Sciences
A …
-
Gilead Sciences stock hits 52-week high at $98.34
11 Nov 2024 16:09 GMT
Gilead Sciences Inc . (NASDAQ:GILD) … recent news, Gilead Sciences has announced its earnings results for the … materials related to the earnings announcement are accessible on … with forward-looking statements.
Gilead Sciences' recent stock performance …
-
Gilead Sciences Announces Third Quarter 2024 Financial Results
06 Nov 2024 21:07 GMT
… the accompanying tables.
About Gilead Sciences
Gilead Sciences, Inc. is a …
$
6,293
Diluted earnings (loss) per share reconciliation:
GAAP … diluted earnings (loss) per share
$
1 …
-
Gilead Sciences Set to Release Quarterly Earnings Amid Positive Analyst Outlook and Promising Clinical Trial Data
06 Nov 2024 10:12 GMT
Gilead Sciences (NASDAQ: GILD) is poised to release its quarterly earnings report … treatment’s commercial prospects.
Gilead Sciences has also seen positive … oncology drug Trodelvy.
Financially, Gilead Sciences boasts a substantial market capitalization …
-
The Dow Jones Industrials Are Winning 2025: 4 Highest-Yielding Dogs of the Dow Are Steals
03 Feb 2025 21:49 GMT
… 8.75 times estimated 2025 earnings and paying investors a strong … , Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to jointly develop and commercialize …
-
Top 10 Takeover Targets of 2025
03 Feb 2025 19:21 GMT
… target—and not just for Gilead Sciences, whose Kite subsidiary partners with … )
Evotec sought to boost its earnings before EBITDA through a “priority …